Global Ampicillin Market to Clock 2.6% CAGR from 2022-28

Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).

China is the largest region of Ampicillin, with a market share nearly 70%. DSM, United Laboratories, CSPC Pharmaceutical, North China Pharmaceutical and Huaxing Pharmaceutical are the top 5 manufacturers of industry, and they had about 70% combined market share.

The global Ampicillin market was valued at US$ 161 million in 2020 and is expected to reach US$ 192.7 million by the end of 2027, growing at a CAGR of 2.6% during 2021-2027.

This report focuses on Ampicillin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ampicillin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Ampicillin Capsules
  • Ampicillin Sodium
  • Ampicillin Granules
  • Ampicillin Tablets
  • Ampicillin Sodium for Injection
  • Ampicillin Sodium and Sulbactam Sodium for Injection
  • Ampicillin Sodium and Cloxacillin Sodium for Injection
  • Others

Segment by Application

  • Adults
  • Kids

By Company

  • DSM
  • ACS Dobfar
  • Kopran
  • Antibioticos
  • United Laboratories
  • Shandong Lukang
  • CSPC Pharmaceutical
  • North China Pharmaceutical
  • Huaxing Pharmaceutical

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479